Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022

Go back to Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
(NASDAQ: SPRB) Delayed: 47.07 --0 (-0%)
Previous Close $47.07    52 Week High
Open $47.07    52 Week Low
Day High $47.07    P/E N/A 
Day Low $47.07    EPS
Volume 100